Does lower total bilirubin reflect reduced antioxidant buffering capacity?

Bilirubin is a potent endogenous antioxidant that plays a critical role in cellular redox homeostasis. Modern research has shifted the view of bilirubin from a mere waste product of heme metabolism to a functional indicator of the body’s systemic antioxidant buffering capacity.

Clinical and mechanistic evidence

The role of bilirubin as a defensive molecule is primarily defined by its ability to neutralize highly reactive oxygen species (ROS), including superoxide anions, hydroxyl radicals, and peroxyl radicals.

• The HO-BVR Redox Cycle: A unique feature of bilirubin’s efficacy is the heme oxygenase-biliverdin reductase (HO-BVR) cycle. When bilirubin reacts with ROS, it is oxidized back into biliverdin. The enzyme biliverdin reductase (BVR) then reduces it back into bilirubin using NADPH. This recycling mechanism allows small concentrations of bilirubin to exert a disproportionately large antioxidant effect—up to 10,000 times its own concentration—protecting vital tissues from oxidative damage.
• Protection against lipid peroxidation: Due to its lipophilic nature, bilirubin is exceptionally effective at intercalating into cell membranes, where it prevents the oxidation of essential lipids more effectively than hydrophilic antioxidants like glutathione or Vitamin C.

Impact of low bilirubin levels

Low serum bilirubin levels (hypobilirubinemia) are clinically recognized as a marker of reduced antioxidant capacity and are frequently correlated with heightened oxidative stress.

• Consumption under stress: In states of high oxidative load, such as exposure to environmental toxins or systemic inflammation, the bilirubin pool can be depleted as it is consumed to neutralize free radicals.
• Biomarkers of damage: Individuals with lower total bilirubin often exhibit significantly higher levels of oxidative damage markers, such as malondialdehyde (MDA), F2-isoprostanes, and 8-hydroxy-2'-deoxyguanosine (8-OHdG).
• Protective associations: Conversely, mildly elevated bilirubin (often seen in Gilbert’s syndrome) is associated with an approximately 37% increase in systemic antioxidant potential and a reduced risk of cardiovascular and metabolic diseases.

Bottom line

Bilirubin is a scientifically validated endogenous antioxidant; lower levels directly reflect a diminished capacity to buffer oxidative stress, increasing vulnerability to systemic oxidative damage.